200 related articles for article (PubMed ID: 38581065)
1. Pyrroloquinoline quinone promotes human mesenchymal stem cell-derived mitochondria to improve premature ovarian insufficiency in mice through the SIRT1/ATM/p53 pathway.
Liu S; Wang Y; Yang H; Tan J; Zhang J; Zi D
Stem Cell Res Ther; 2024 Apr; 15(1):97. PubMed ID: 38581065
[TBL] [Abstract][Full Text] [Related]
2. Danggui Shaoyao San protects cyclophosphamide-induced premature ovarian failure by inhibiting apoptosis and oxidative stress through the regulation of the SIRT1/p53 signaling pathway.
Chen H; Zhang G; Peng Y; Wu Y; Han X; Xie L; Xu H; Chen G; Liu B; Xu T; Pang M; Hu C; Fan H; Bi Y; Hua Y; Zhou Y; Luo S
J Ethnopharmacol; 2024 Apr; 323():117718. PubMed ID: 38181933
[TBL] [Abstract][Full Text] [Related]
3. Pyrroloquinoline Quinone, a Redox-Active o-Quinone, Stimulates Mitochondrial Biogenesis by Activating the SIRT1/PGC-1α Signaling Pathway.
Saihara K; Kamikubo R; Ikemoto K; Uchida K; Akagawa M
Biochemistry; 2017 Dec; 56(50):6615-6625. PubMed ID: 29185343
[TBL] [Abstract][Full Text] [Related]
4. Ningxin-Tongyu-Zishen formula alleviates the senescence of granulosa cells on D-galactose-induced premature ovarian insufficiency mice.
Ma JW; Xiong ZY; Cai XC; Li X; Ren SY; An SQ; Zhang ZY; Zhang YZ
Aging (Albany NY); 2024 Feb; 16(5):4541-4562. PubMed ID: 38428403
[TBL] [Abstract][Full Text] [Related]
5. Human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation improves ovarian function in rats with premature ovarian insufficiency (POI) at least partly through a paracrine mechanism.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Wang Z; Tang D; Luo Y; Xiong Z
Stem Cell Res Ther; 2019 Jan; 10(1):46. PubMed ID: 30683144
[TBL] [Abstract][Full Text] [Related]
6. Zigui-Yichong-Fang protects against cyclophosphamide-induced premature ovarian insufficiency via the SIRT1/Foxo3a pathway.
Xiu Z; Tang S; Kong P; Yan M; Tong X; Liu X; Liang X; Li R; Duan Y
J Ethnopharmacol; 2023 Oct; 314():116608. PubMed ID: 37150421
[TBL] [Abstract][Full Text] [Related]
7. Fetal liver mesenchymal stem cells restore ovarian function in premature ovarian insufficiency by targeting MT1.
Huang B; Qian C; Ding C; Meng Q; Zou Q; Li H
Stem Cell Res Ther; 2019 Nov; 10(1):362. PubMed ID: 31783916
[TBL] [Abstract][Full Text] [Related]
8. Effects of low-intensity pulsed ultrasound (LIPUS)-pretreated human amnion-derived mesenchymal stem cell (hAD-MSC) transplantation on primary ovarian insufficiency in rats.
Ling L; Feng X; Wei T; Wang Y; Wang Y; Zhang W; He L; Wang Z; Zeng Q; Xiong Z
Stem Cell Res Ther; 2017 Dec; 8(1):283. PubMed ID: 29258619
[TBL] [Abstract][Full Text] [Related]
9. Effects of Human Amnion-Derived Mesenchymal Stem Cell (hAD-MSC) Transplantation In Situ on Primary Ovarian Insufficiency in SD Rats.
Feng X; Ling L; Zhang W; Liu X; Wang Y; Luo Y; Xiong Z
Reprod Sci; 2020 Jul; 27(7):1502-1512. PubMed ID: 31953773
[TBL] [Abstract][Full Text] [Related]
10. Combination of bone marrow mesenchymal stem cells and moxibustion restores cyclophosphamide-induced premature ovarian insufficiency by improving mitochondrial function and regulating mitophagy.
Lu G; Li HX; Song ZW; Luo J; Fan YL; Yin YL; Shen J; Shen MH
Stem Cell Res Ther; 2024 Apr; 15(1):102. PubMed ID: 38589967
[TBL] [Abstract][Full Text] [Related]
11. Quercetin alleviates cyclophosphamide-induced premature ovarian insufficiency in mice by reducing mitochondrial oxidative stress and pyroptosis in granulosa cells.
Chen Y; Zhao Y; Miao C; Yang L; Wang R; Chen B; Zhang Q
J Ovarian Res; 2022 Dec; 15(1):138. PubMed ID: 36572950
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1/AMPK/PGC-1α pathway.
Yuan Y; Shi M; Li L; Liu J; Chen B; Chen Y; An X; Liu S; Luo R; Long D; Zhang W; Newsholme P; Cheng J; Lu Y
Clin Sci (Lond); 2016 Dec; 130(23):2181-2198. PubMed ID: 27613156
[TBL] [Abstract][Full Text] [Related]
13. Effects of Low-Intensity Pulsed Ultrasound on the Migration and Homing of Human Amnion-Derived Mesenchymal Stem Cells to Ovaries in Rats With Premature Ovarian Insufficiency.
Ling L; Hou J; Wang Y; Shu H; Huang Y
Cell Transplant; 2022; 31():9636897221129171. PubMed ID: 36282038
[TBL] [Abstract][Full Text] [Related]
14. Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression.
Chowanadisai W; Bauerly KA; Tchaparian E; Wong A; Cortopassi GA; Rucker RB
J Biol Chem; 2010 Jan; 285(1):142-52. PubMed ID: 19861415
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of human umbilical cord mesenchymal stem cell-derived microvesicles on premature ovarian insufficiency in mice.
Yang Z; Du X; Wang C; Zhang J; Liu C; Li Y; Jiang H
Stem Cell Res Ther; 2019 Aug; 10(1):250. PubMed ID: 31412919
[TBL] [Abstract][Full Text] [Related]
16. Pyrroloquinoline Quinone Resists Denervation-Induced Skeletal Muscle Atrophy by Activating PGC-1α and Integrating Mitochondrial Electron Transport Chain Complexes.
Kuo YT; Shih PH; Kao SH; Yeh GC; Lee HM
PLoS One; 2015; 10(12):e0143600. PubMed ID: 26646764
[TBL] [Abstract][Full Text] [Related]
17. Pyrroloquinoline quinone increases the expression and activity of Sirt1 and -3 genes in HepG2 cells.
Zhang J; Meruvu S; Bedi YS; Chau J; Arguelles A; Rucker R; Choudhury M
Nutr Res; 2015 Sep; 35(9):844-9. PubMed ID: 26275361
[TBL] [Abstract][Full Text] [Related]
18. Effects of VEGF
Vural B; Duruksu G; Vural F; Gorguc M; Karaoz E
Stem Cell Rev Rep; 2019 Aug; 15(4):558-573. PubMed ID: 31037585
[TBL] [Abstract][Full Text] [Related]
19. Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Improve Ovarian Function and Proliferation of Premature Ovarian Insufficiency by Regulating the Hippo Signaling Pathway.
Li Z; Zhang M; Zheng J; Tian Y; Zhang H; Tan Y; Li Q; Zhang J; Huang X
Front Endocrinol (Lausanne); 2021; 12():711902. PubMed ID: 34456868
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage.
Park HS; Chugh RM; Seok J; Cetin E; Mohammed H; Siblini H; Liakath Ali F; Ghasroldasht MM; Alkelani H; Elsharoud A; Ulin M; Esfandyari S; Al-Hendy A
Stem Cell Res Ther; 2023 Jun; 14(1):165. PubMed ID: 37340468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
